Monograph Capital
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
- United Kingdom
Investment stages
- Pre-Seed
- Seed
Industries
- Pharma
- Diagnostics
- Biotechnology
- Health Tech
- Medical Devices
- Digital Health
About
Monograph Capital is a distinguished venture capital and private equity firm dedicated to advancing innovative life sciences companies that are poised to transform healthcare. With a team of accomplished professionals, including M.D.s and PhDs, Monograph Capital leverages decades of expertise in biomedical research, clinical medicine, and drug development to identify and support high-potential investments. The firm is committed to fostering the growth of pioneering technologies and therapies that address critical medical challenges, ultimately improving patient outcomes and enhancing the quality of life. Through strategic partnerships and a robust network, Monograph Capital empowers visionary entrepreneurs to realize their impactful solutions in the life sciences sector.
Monograph Capital is a distinguished venture capital and private equity firm dedicated to advancing innovative life sciences companies that are poised to transform healthcare. With a team of accomplished professionals, including M.D.s and PhDs, Monograph Capital leverages decades of expertise in biomedical research, clinical medicine, and drug development to identify and support high-potential investments. The firm is committed to fostering the growth of pioneering technologies and therapies that address critical medical challenges, ultimately improving patient outcomes and enhancing the quality of life. Through strategic partnerships and a robust network, Monograph Capital empowers visionary entrepreneurs to realize their impactful solutions in the life sciences sector.
Investment Thesis
Monograph Capital invests in early stage biotech and life sciences companies, with a focus on innovative therapeutic and diagnostic technologies.
Manager's Experience
With a strong background in venture capital, the fund manager has successfully led over 30 investments predominantly in the technology and healthcare sectors across North America and Europe. Their operator-first approach emphasizes deep operational insights to drive value creation, resulting in notable exits that include several high-profile acquisitions. Specializing in early to growth-stage investments, they leverage a data-driven strategy to identify transformative opportunities. The manager’s strategic vision has consistently positioned the fund at the forefront of emerging market trends.